Without exposure to the stimuli, none of the cells sorted with CD45 expressed Oct4-GFP regardless of the culture period in LIF+B27 medium. In contrast, a 30-min treatment with low-pH medium (25-min incubation followed by 5-min centrifugation; Fig. 1a; the most effective range was pH 5.4–5.8; Extended Data Fig. 1a) caused the emergence of substantial numbers of spherical clusters that expressed Oct4-GFP in day-7 culture (Fig. 1b). Substantial numbers of GFP+ cells appeared in all cases performed with neonatal splenic cells (n = 30 experiments).
The emergence of Oct4-GFP+ cells at the expense of CD45+ cells was also observed by flow cytometry (Fig. 1c, top, and Extended Data Fig. 1b, c). We next fractionated CD45+ cells into populations positive and negative for CD90 (T cells), CD19 (B cells) and CD34 (haematopoietic progenitors18), and subjected them to low-pH treatment. Cells of these fractions, including T and B cells, generated Oct4-GFP+ cells at an efficacy comparable to unfractionated CD45+ cells (25–50% of surviving cells on day 7), except for CD34+ haematopoietic progenitors19, which rarely produced Oct4-GFP+ cells (<2%; Extended Data Fig. 1d).
Among maintenance media for pluripotent cells, the appearance of Oct4-GFP+ cells was most efficient in LIF+B27 medium, and did not occur in mouse epiblast-derived stem-cell (EpiSC) medium (Extended Data Fig. 1e). The presence or absence of LIF during days 0–2 did not substantially affect the frequency of Oct4-GFP+ cell generation on day 7 (Extended Data Fig. 1f), whereas the addition of LIF during days 4–7 was not sufficient, indicating that LIF dependency started during days 2–4.
Most of the surviving cells on day 1 were still CD45+ and Oct4-GFP−. On day 3, the total cell numbers were reduced to between one-third to one-half of the day 0 population (Fig. 1d; see Extended Data Fig. 1g, h for apoptosis アナリシス), and a substantial number of total surviving cells became Oct4-GFP+ (Fig. 1d), albeit with relatively weak signal intensity. On day 7, a significant number of Oct4-GFP+CD45− cells (one-half to two-thirds of total surviving cells) constituted a distinct population from the Oct4-GFP−CD45− cells (Fig. 1c, top, day 7, and Fig. 1d). No obvious generation of Oct4-GFP+CD45− populations was seen in non-treated CD45+ cells cultured similarly but without low-pH treatment (Fig. 1c, bottom).
Low-pH-treated CD45+ cells, but not untreated cells, gradually turned on GFP signals over the first few days (Fig. 1e, Supplementary Videos 1 and 2 and Extended Data Fig. 2a), whereas CD45 immunoreactivity became gradually reduced in the cells that demonstrated Oct4-GFP expression (Fig. 1f and Extended Data Fig. 2b). By day 5, the Oct4-GFP+ cells attached together and formed clusters by accretion. These GFP+ clusters (but not GFP− cells) were quite mobile and often showed cell processes on moving (Supplementary Video 1).
The Oct4-GFP+ cells demonstrated a characteristic small cell size with little cytoplasm and also showed a distinct fine structure of the nucleus compared with that of parental CD45+ lymphocytes (Fig. 1g). The Oct4-GFP+ cells on day 7 were smaller than non-treated CD45+ cells (Fig. 1g, h and Extended Data Fig. 2c) and embryonic stem (ES) cells (Fig. 1h), both of which are generally considered to be small in size. The diameter of low-pH-treated CD45+ cells became reduced during the first 2 days, even before they started Oct4-GFP expression (Fig. 1f), whereas the onset of GFP expression was not accompanied by cell divisions. Consistent with this, no substantial 5-ethynyl-2′-deoxyuridine (EdU) uptake was observed in the Oct4-GFP+ cells after the stressor (Extended Data Fig. 2d).
The lack of substantial proliferation argues against the possibility that CD45− cells, contaminating as a very minor population in the FACS-sorted CD45+ cells, quickly grew and formed a substantial Oct4-GFP+ population over the first few days after the low-pH treatment. In addition, genomic rearrangements of Tcrb (T-cell receptor gene) were observed in Oct4-GFP+ cells derived from FACS-purified CD45+ cells and CD90+CD45+ T cells (Fig. 1i, lanes 4, 5, and Extended Data Fig. 2e–g), indicating at least some contribution from lineage-committed T cells. Thus, Oct4-GFP+ cells were generated de novo from low-pH-treated CD45+ haematopoietic cells by reprogramming, rather than by simple selection of stress-enduring cells.
expressed pluripotency-related marker proteins (Oct4, SSEA1, Nanog and E-cadherin; Fig. 2a) and marker genes (Oct4, Nanog, Sox2, Ecat1 (also called Khdc3), Esg1 (Dppa5a), Dax1 (Nrob1) and Rex1 (Zfp42); Fig. 2b and Extended Data Fig. 3a) in a manner comparable to those seen in ES cells. Moderate levels of expression of these pluripotency marker genes were observed on day 3 (Fig. 2b and Extended Data Fig. 3b). Notably, the Oct4-GFP+ cells on day 3, but not on day 7, expressed early haematopoietic marker genes such as Flk1 (also called Kdr) and Tal1 (Extended Data Fig. 3c), indicating that Oct4-GFP+ cells on day 3, as judged by their expression pattern at the population level, were still in a dynamic process of conversion.
On day 7, unlike CD45+ cells and like ES cells, low-pH-induced Oct4-GFP+ cells displayed extensive demethylation at the Oct4 and Nanog promoter areas (Fig. 2c), indicating that these cells underwent a substantial reprogramming of epigenetic status in these key genes for pluripotency.
In vitro differentiation assays demonstrated that low-pH-induced Oct4-GFP+ cells gave rise to three-germ-layer derivatives (Fig. 2d) as well as visceral endoderm-like epithelium (Extended Data Fig. 3d). When grafted into mice, low-pH-induced Oct4-GFP+ cell clusters formed teratomas (40%, n = 20) (Fig. 2e and Extended Data Fig. 4a–c) but no teratocarcinomas that persistently contained Oct4-GFP+ cells (n = 50). Because some cellular variation was observed in the signal levels of Oct4-GFP within the clusters, we sorted GFP-strong cells (a major population) and GFP-dim cells (a minor population) by FACS on day 7 and separately injected them into mice. In this case, only GFP-strong cells formed teratomas (Extended Data Fig. 4d).
